PE/VC investors
Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.
Investors (6,250)
Investor
Description
More information
Velos Partners
Velos Partners is a consumer growth capital firm investing in companies at the intersection of consumer and technology where the exponential pace of innovation is transforming traditional consumer behavior and business models. The firm has offices in Los Angeles, London, and Singapore investing across three sectors: retail innovation, health and wellness, and luxury and entertainment.
venBio Partners
![venBio Partners]()
We take a unique approach to investments, and it has to do with the people in, behind, and associated with our firm. We make all investments as a team; every member of our firm is involved in every investment that we make. We seek the advice of a wide range of expert advisors. Our Limited Partners include both strategic partners (several large biotech and pharma companies) and qualified financial investors. We listen to our LPs and include their expertise in our diligence. We believe we make better decisions this way.
venBio invests in promising companies at various stages: from early to late stage, and from academic startups to spinouts. We tend to lead most of our investments, and we enjoy building syndicates and teams.
We are mindful of potential acquisition partners from the outset, and we ensure that our companies are best positioned to meet their requirements. This includes IP, CMC, and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Our team’s expertise and involvement helps companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that we work with.
We seek out teams who are developing treatments that will have a meaningful impact on patient care. Our mission is to put our companies in the best possible position to succeed, by helping teams think through the best development plan to bring these therapies to patients.
Founded in 2011, venBio’s venture funds comprise nearly $1 billion of committed capital. We are currently investing out of our third fund of approximately $394M committed capital. Our team combines scientific, clinical and operating experience in our investment decisions.
Vencapital
![Vencapital]()
Vencapital is a venture accelerator that provides entry-level experience for minorities and women seeking career opportunity in venture finance We partner with Venture firms and Accelerator programs to build the talent muscle needed for growing new ventures.
Vendep Capital
Vendep Capital is a fresh 32Me pre-A round venture capital fund based in Helsinki and founded by 3 partners with complimentary background as entrepreneurs (iRent, Nettiauto.com, Koulukaverit.com), investors (Alphasense, Brella, Meontrust + others) and heads of business operations (F-secure, Nokia, Reuters).
<br />
<br />
Vendep Capital Fund invests primarily in Finnish startups offering software to B2B customers. In April 2017, Vendep Capital launched a new €40 million fund aimed at SaaS startups. The fund was raised from Finnish private and institutional investors such as Tesi (Finnish Industry Investment Ltd) and The Finnish Innovation Fund Sitra. The fund may make investments alone or as part of a syndicate.
Vendis Capital Management
Focus on small to medium-sized companies (SMEs) – The companies we invest in typically generate consumer sales between 10 and 120 million Euro and have an operating cash flow (EBITDA) between 2 and 15 million Euro. We believe SMEs are particularly attractive because they often provide significant value creation potential. The companies we invest in are either entrepreneurial players in new, up-and-coming segments, innovators in more mature markets, or established leaders in small niche markets. Our focus is not just on growing those companies, but also on building the teams and scaling the companies to help them reach the next stage of development. Our sector specialization is key in putting this SME-focused investment strategy into effect. By leveraging our industry experience and network, we are uniquely positioned to identify and help realize these opportunities.
Venionaire Capital
![Venionaire Capital]()
Venionaire Capital is a corporate finance and venture capital advisory and offers a wide range of services in a variety of tech-related sectors and industries. Since the foundation in 2012 the company advised successfully more than 50 Startups and closed transactions with an overall volume of about 350 Million Euros. Throughout the past years Venionaire Capital made early-stage lead- and co-investments and managed to build a portfolio of holdings.
Since 2015 the Venionaire Investment GmbH (a majority owned subsidiary of Venionaire Capital) is the first registered European Alternative Investment Fund Manager (AIFM) by the Austrian Financial Markets Authority, with a licence for transnational management of EuVECA funds. Venionaire aims to raise a 100 Millionen Euro Venture Capital Fund, which will support substantial growth for European and especially Austrian and German headquartered startups.
Venrex Investment Management
![Venrex Investment Management]()
Venrex is a UK based venture capital fund that provides equity funding to startups and small businesses, with a focus on technology enabled companies within the consumer retail and fintech industries. Founded in 2003 by Tom Fleming, Venrex has invested in over 70 companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock continues a tradition of partnering with entrepreneurs to establish successful, enduring companies. With a primary focus on technology and healthcare, portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Nest, SlideShare and Tudou.
Ventech
Ventech is a venture capital investment fund, present for 17 years on the Paris market and having nearly € 400M under management. Ventech is investing in the first round of financing in recent companies in the fields of Information Technology. We are notably investors in Webedia, VestiaireCollective, Withigs, Believe Digital or Curse.
Ventech China
![Ventech China]()
Ever-accelerating digitalization is deeply transforming each sector of our economy at breathtaking speed. Leaning on breakthrough technology and new types of usage combined with smart business models, innovation is the ultimate fuel for emerging international leaders addressing large and high-growth markets.
